Large-scale SPPS capacity in Braine-l’Alleud starts production
See media releaseInnovation for large-scale peptide production
See our presentation at a recent broker event related to GLP-1
Download presentationCreating the future in peptides
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usAhead on green peptide chemistry
Together we improve process performance while reducing the environmental footprint
Learn moreMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Large-scale SPPS capacity in Braine-l’Alleud starts production
16 Dec 2024 - Baar, 16 December 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, announces the start of production with the […]
Read morePeptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand
13 Nov 2024 - Presented at TIDES Europe, November 13, 2024 Speaker: Jan Pawlas, Scientist Global Development Abstract: The peptide market is strongly impacted by the evolution of the development pipeline, […]
Read more